The Journal of Immunology, Vol 138, Issue 7 2177-2183, Copyright © 1987 by American Association of Immunologists

ARTICLES

Oxidation of salicylates by stimulated granulocytes: evidence that these drugs act as free radical scavengers in biological systems

AL Sagone Jr and RM Husney

Although salicylates have been used for centuries as treatment of inflammatory diseases, the mechanism of action of these drugs is still not clear. Aspirin (acetylsalicylic acid) and other nonsteroidal anti- inflammatory drugs (NSAID) inhibit prostaglandin biosynthesis, a property that appears to explain part of their anti-inflammatory activity. However, this mechanism does not appear to explain the anti- inflammatory properties of salicylic acid, which is a major metabolite of ASA in vivo. Results of prior studies in our laboratory have established that benzoic acid, the parent compound of the salicylate group of drugs, is decarboxylated and hydroxylated by the hydroxyl free radical (OH.) produced by stimulated granulocytes. These observations suggested that salicylates might be similarly metabolized by granulocytes. If so, the capacity of salicylates to rapidly react with OH. might relate directly to their known anti-inflammatory properties. Preliminary experiments established that salicylic acid and aspirin were decarboxylated by the hydroxyl free radical generated by the enzyme system xanthine-xanthine oxidase. We then studied the metabolism of salicylates by human granulocytes. Unstimulated granulocyte suspensions did not oxidize ASA or salicylic acid. However, suspensions stimulated by opsonized zymosan particles rapidly oxidized both substrates in pharmacological concentrations. The rate of oxidation of salicylic acid was 16-fold higher than benzoic acid, whereas the rate of oxidation of ASA was four-fold higher. The reaction was oxygen dependent and could be inhibited by known hydroxyl scavengers, particularly dimethylthiourea. The reaction could also be inhibited by superoxide dismutase and azide, indicating that O-2 and heme or an iron- dependent enzyme were required for the reaction. The reaction was not impaired by compounds known to react with the HOCL and the chloramines generated by stimulated PMN. Furthermore, salicylic acid in high concentrations did not impair the HMPS pathway, the production of O-2 or the production of H2O2 by granulocytes. These data provide evidence that salicylates are rapidly oxidized by the hydroxyl free radical produced by granulocytes and not O-2, H2O2, or HOCL. This capacity of salicylates to react rapidly and selectively react with OH. may directly relate to their anti-inflammatory properties. In addition, results of our experiments indicate that stimulated granulocytes acquire the capacity to metabolize these drugs. Therefore, several metabolites of salicylates may be produced at a site of inflammation, all of which may have altered biological activity compared with the parent compound.

This article has been cited by other articles:

				A. Jafarnejad, S. Z. Bathaie, M. Nakhjavani, and M. Z. Hassan Investigation of the Mechanisms Involved in the High-Dose and Long-Term Acetyl Salicylic Acid Therapy of Type I Diabetic Rats J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 850 - 857. [Abstract] [Full Text] [PDF]

				R. P Raghavan, D. W Laight, K. M Shaw, and M. H Cummings Review: Aspirin and diabetes The British Journal of Diabetes & Vascular Disease, March 1, 2006; 6(2): 74 - 82. [Abstract] [PDF]

				K. J. Reszka, L. H. Britigan, and B. E. Britigan Oxidation of Anthracyclines by Peroxidase Metabolites of Salicylic Acid J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 283 - 290. [Abstract] [Full Text] [PDF]

				L. Belhassen, G. Pelle, J.-L. Dubois-Rande, and S. Adnot Improved endothelial function by the thromboxane a2 receptor antagonist s 18886 in patients with coronary artery disease treated with aspirin J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1198 - 1204. [Abstract] [Full Text] [PDF]

				C.-J. Chen, S.-L. Raung, M.-D. Kuo, and Y.-M. Wang Suppression of Japanese encephalitis virus infection by non-steroidal anti-inflammatory drugs J. Gen. Virol., August 1, 2002; 83(8): 1897 - 1905. [Abstract] [Full Text] [PDF]

				E. Speir, Z.-X. Yu, V. J. Ferrans, E.-S. Huang, and S. E. Epstein Aspirin Attenuates Cytomegalovirus Infectivity and Gene Expression Mediated by Cyclooxygenase-2 in Coronary Artery Smooth Muscle Cells Circ. Res., July 27, 1998; 83(2): 210 - 216. [Abstract] [Full Text] [PDF]

				S. Husain, N. P. Andrews, D. Mulcahy, J. A. Panza, and A. A. Quyyumi Aspirin Improves Endothelial Dysfunction in Atherosclerosis Circulation, March 3, 1998; 97(8): 716 - 720. [Abstract] [Full Text] [PDF]

				L. Xia, J. Pan, L. Yao, and R. P. McEver A Proteasome Inhibitor, an Antioxidant, or a Salicylate, but not a Glucocorticoid, Blocks Constitutive and Cytokine-Inducible Expression of P-Selectin in Human Endothelial Cells Blood, March 1, 1998; 91(5): 1625 - 1632. [Abstract] [Full Text] [PDF]

				C. Weber, W. Erl, A. Pietsch, and P. C. Weber Aspirin Inhibits Nuclear Factor–{kappa}B Mobilization and Monocyte Adhesion in Stimulated Human Endothelial Cells Circulation, April 1, 1995; 91(7): 1914 - 1917. [Abstract] [Full Text]